A systematic review of Helicobacter pylori eradication treatment schedules in children

G Oderda1, A Rapa, G Bona

  • 1Clinica Paediatrica, Università Piemonte Orientale, Novara, Italy.

Insights

Dual therapies for Helicobacter pylori infection in children are as effective as triple therapies. Longer courses of proton pump inhibitor-based triple therapies do not improve efficacy in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Pharmacology

Background:

  • Helicobacter pylori infection is a common pediatric concern.
  • Optimal treatment regimens for children remain under investigation.

Purpose of the Study:

  • To systematically review and analyze data on the efficacy of different treatment schedules for H. pylori in children.
  • To compare the effectiveness of various monotherapy, dual therapy, and triple therapy regimens.

Main Methods:

  • Systematic literature review of published articles and abstracts from 1987 to 1999.
  • Inclusion of English and French papers, letters, and abstracts.
  • Extraction and analysis of results on H. pylori eradication in pediatric populations.

Main Results:

  • Monotherapy and dual therapy with an antisecretory drug plus one antibiotic showed low efficacy.
  • Dual therapies with bismuth plus one antibiotic or two antibiotics for ≥2 weeks were effective.
  • Bismuth-based triple therapies were more effective with longer duration; PPI-based triple therapies showed similar efficacy regardless of duration.

Conclusions:

  • Dual therapies appear as effective as triple therapies in pediatric H. pylori treatment.
  • Extended duration of proton pump inhibitor-based triple therapies does not enhance efficacy in children.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...